1 Min Read
Jan 12 (Reuters) - Sangui BioTech International Inc :
* Revenues of $36,000 in the first half-year; Granulox license income increased by 33 pct Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.